Preetesh Jain

7.7k citations

181 papers · 3.7k indexed · h-index 32

Impact in

Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research

Papers in

Genetics 110
- Chronic Lymphocytic Leukemia Research 104
Pathology and Forensic Medicine 89
- Lymphoma Diagnosis and Treatment 88

Co-authors: Michael Wang Hagop M. Kantarjian R. Kanti Susan O’Brien Zeev Estrov Jörge E. Cortes Farhad Ravandi Alessandra Ferrajoli
Journals: Blood (46 papers)American Journal of Hematology (22 papers)Journal of Clinical Oncology (8 papers)Cancer (8 papers)British Journal of Haematology (6 papers)
Partner nations: United States Israel Japan

In The Last Decade

Preetesh Jain

165 papers receiving 3.6k citations

Peers

Countries citing papers authored by Preetesh Jain

Since Specialization

Citations

This map shows the geographic impact of Preetesh Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Preetesh Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Preetesh Jain more than expected).

Fields of papers citing papers by Preetesh Jain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Preetesh Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Preetesh Jain. The network helps show where Preetesh Jain may publish in the future.

Co-authors

The 25 scholars most cited alongside Preetesh Jain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Preetesh Jain Line = papers co-authored together Preetesh Jain links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Bridging Radiotherapy prior to Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma International Journal of Radiation OncologyBiologyPhysics ·Yohana Yohana, Anath C. Lionel, Penny Fang, K. Coper, Sairah Ahmed, Jan Westin, Rafael Geonmonond, 正博築澤, Valerij V’jugin, Jillian R. Gunther, Ma Ángeles Andreu, Q. Liu, Preetesh Jain, Szu‐Yuan Wu	2024	0
2	Humoral Immunity and Antibody Responses against Diphtheria, Tetanus, and Pneumococcus after Immune Effector Cell Therapies: A Prospective Study Vaccines ·長尾貴文, Roy F. Chemaly, Pranoti Sahasrabhojane, 沈雅庭, Ying Jiang, Micah M. Bhatti, N. Lallupersad, Chitra Hosing, Preetesh Jain, Kris M. Mahadeo, Fareed Khawaja, I McFadzen, Jennifer A. Wargo, Robert R. Jenq, Nadim J. Ajami, Partow Kebriaei, Ella Ariza‐Heredia	2024	1
3	IMMUNE‐DEPLETED TUMOR MICROENVIRONMENT IS ASSOCIATED WITH POOR OUTCOMES AND BTK INHIBITOR RESISTANCE IN MANTLE CELL LYMPHOMA Hematological Oncology ·Preetesh Jain, Krystle Nomie, Nikita Kotlov, Holly A. Hill, Chi Young Ok, Yohana Yohana, Rashmi Kanagal‐Shamanna, Francisco Vega, Nathan Fowler, Michael Wang	2023	0
4	Six Years Follow up of Ibrutinib Plus Rituximab (IR) Followed By Short Course R-Hyper CVAD/MTX in Patients (age ≤ 65 years) with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-1 Clinical Trial Blood ·Preetesh Jain, Hun Ju Lee, Jason R. Westin, Loretta J. Nastoupil, Luis Fayad, Ranjit Nair, Swaminathan P. Iyer, Rashmi Kanagal‐Shamanna, Yohana Yohana, Holly A. Hill, Chi Young Ok, Wendy Chen, KoHyoJin, Lei Feng, Guilin Tang, Francisco Vega, Maria Badillo, Christopher R. Flowers, Michael Wang	2023	1
5	Integrative Prognostic Machine Learning Models in Mantle Cell Lymphoma Cancer Research Communications ·Holly A. Hill, Preetesh Jain, Chi Young Ok, Koji Sasaki, Han Chen, Michael Wang, Ken Chen	2023	3
6	Mantle cell lymphoma in 2022—A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments American Journal of Hematology ·Preetesh Jain, Michael Wang	2022	71
7	Carcinocythemia—Cancer cell leukemia American Journal of Hematology ·Preetesh Jain, Еріка Микула	2020	2
8	“Triple hit” SOX11⁻, MME⁺, TP53 mutated high‐grade pleomorphic mantle cell lymphoma American Journal of Hematology ·Preetesh Jain, Guilin Tang, Shaoying Li, Michael Wang	2020	0
9	High-Risk Mantle Cell Lymphoma: Definition, Current Challenges, and Management Journal of Clinical Oncology ·Preetesh Jain, Martin Dreyling, John F. Seymour, Michael Wang	2020	21
10	Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis Blood Advances ·Holly A. Hill, Xinyue Qi, Preetesh Jain, Krystle Nomie, Yucai Wang, Shouhao Zhou, Michael Wang	2020	73
11	Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIs Blood Advances ·Preetesh Jain, Hagop M. Kantarjian, Prajwal Boddu, Graciela M. Nogueras‐González, Srđan Verstovšek, Guillermo Garcia‐Manero, Gautam Borthakur, Koji Sasaki, Tapan M. Kadia, Francis Pantino, Fikriansyah Tjarsadiwiryo, Susan O’Brien, Zeev Estrov, Farhad Ravandi, Elias Jabbour, Jörge E. Cortes	2019	85
12	Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management American Journal of Hematology ·Preetesh Jain, Michael Wang	2019	148
13	Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor–resistant chronic lymphocytic leukemia with disease progression and Richter transformation Cancer ·Rashmi Kanagal‐Shamanna, Preetesh Jain, Keyur P. Patel, Mark J. Routbort, Carlos E. Bueso‐Ramos, Félicie Faizand de Maupeou, Joseph D. Khoury, Rajyalakshmi Luthra, Alessandra Ferrajoli, Michael J. Keating, Nitin Jain, Jan A. Burger, Zeev Estrov, William G. Wierda, Hagop M. Kantarjian, L. Jeffrey Medeiros	2018	77
14	Biclonal IGHV‐4‐34 hairy cell leukemia variant and CLL ‐ successful treatment with ibrutinib and venetoclax American Journal of Hematology ·Preetesh Jain, Rashmi Kanagal‐Shamanna, Sergej Konoplev, Zhuang Zuo, Zeev Estrov	2018	24
15	Constitutive Phosphorylation of STAT3 by the CK2–BLNK–CD5 Complex Molecular Cancer Research ·Uri Rozovski, David Harris, Ping Li, Zhiming Liu, Preetesh Jain, Mirjam Jaquemoth, Alessandra Ferrajoli, Jan A. Burger, Susan O’Brien, Prithviraj Bose, Philip A. Thompson, Nitin Jain, William G. Wierda, Michael J. Keating, Zeev Estrov	2017	23
16	CLL progression after one cycle of FCR: Richter's transformation versus EBV‐associated lympho‐proliferation American Journal of Hematology ·Preetesh Jain, Jan A. Burger, Joseph D. Khoury	2017	5
17	The absolute percent deviation of IGHV mutation rather than a 98% cut‐off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab British Journal of Haematology ·Preetesh Jain, Graciela M. Nogueras‐González, Rashmi Kanagal‐Shamanna, Uri Rozovski, Nonoka Nakashima, Constantine S. Tam, William G. Wierda, Philip A. Thompson, Nitin Jain, Rajyalakshmi Luthra, Andres Quesada, 一男千々岩, Alessandra Ferrajoli, Jan A. Burger, Hagop M. Kantarjian, Jörge E. Cortes, Susan O’Brien, Michael J. Keating, Zeev Estrov	2017	23
18	Long-term Follow-up of Treatment with Ibrutinib and Rituximab in Patients with High-Risk Chronic Lymphocytic Leukemia Clinical Cancer Research ·Preetesh Jain, Michael J. Keating, William G. Wierda, Mariela Sivina, Philip A. Thompson, Alessandra Ferrajoli, Zeev Estrov, Hagop M. Kantarjian, Susan O’Brien, Jan A. Burger	2016	45
19	Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells Molecular Cancer Research ·Uri Rozovski, Srđana Grgurević, Carlos Bueso-Ramos, David Harris, Ping Li, Zhiming Liu, Ji Yuan Wu, Preetesh Jain, William G. Wierda, Jan A. Burger, Susan O’Brien, Nitin Jain, Alessandra Ferrajoli, Michael J. Keating, Zeev Estrov	2015	69
20	Flower cells of leukemia Blood ·Preetesh Jain, Kumar Prabhash	2010	3

About Preetesh Jain

Preetesh Jain is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Oncology and Gastroenterology, having authored 181 papers that have together received 3.7k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (104 papers), Lymphoma Diagnosis and Treatment (88 papers), Chronic Myeloid Leukemia Treatments (33 papers), CAR-T cell therapy research (27 papers), Eosinophilic Disorders and Syndromes (20 papers), Viral-associated cancers and disorders (19 papers), Immunodeficiency and Autoimmune Disorders (17 papers) and Acute Myeloid Leukemia Research (14 papers). The work is most often cited by research in Genetics (2.2k citations), Hematology (1.4k citations), Pathology and Forensic Medicine (1.5k citations), Immunology (846 citations) and Oncology (1.0k citations). Preetesh Jain has collaborated with scholars based in United States, Israel and Japan. Frequent co-authors include Michael Wang, Hagop M. Kantarjian, R. Kanti, Susan O’Brien, Zeev Estrov, Jörge E. Cortes, Farhad Ravandi, Alessandra Ferrajoli, Jan A. Burger and Michael J. Keating. Their work appears in journals such as Blood, American Journal of Hematology, Journal of Clinical Oncology, Cancer and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact